Search
Candel Therapeutics Inc
CADLAdd to Watchlist
9.830USD
-0.050-0.51%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
720.25MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Candel Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 33.26%, representing a quarter-over-quarter decrease of 33.22%. The largest institutional shareholder is Steven Cohen, holding a total of 65.26K shares, representing 0.15% of shares outstanding, with 2.53% increase in holdings.